Consulting Group Inc Biostrategies serves as Executive at Enhance Skin Products Inc, where they oversee executive responsibilities. Since joining the company, Consulting Group Inc Biostrategies has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 12, 2010 involved selling 825,000 shares valued at $0.
Consulting Group Inc Biostrategies currently holds 17,508,334 shares of Enhance Skin Products Inc (EHSK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Consulting Group Inc Biostrategies has been a net neutral trader of EHSK stock. They have purchased $0 and sold $0 worth of shares.
Consulting Group Inc Biostrategies's most recent insider trade was on May 12, 2010, when they sold 825,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |